View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
October 5, 2021

FDA grants EUA to Acon Laboratories’ Covid-19 antigen home test

The authorisation of Acon’s antigen test increases the availability of rapid, at-home tests in the US.

The US F ood and Drug Administration (F DA) has granted emergency use authorization (EUA) to Acon Laboratories’ F lowflex COVID-19 Antigen Home Test.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

F lowflex is an over the counter (OTC) antigen test, which uses nasal swab specimens from individuals suspected of active Covid-19.

Individuals aged 14 years and above can use the new home test for self-testing. It can also be used for children aged two years or older with nasal swabs collected by adults.

F lowflex can currently be purchased without a prescription in major retail stores and will be available online soon.

The authorisation of the antigen test adds to the increasing list of Covid-19 tests that can be used at home without a prescription.

The F DA expects at-home Covid-19 testing capacity in the country to double over the next several weeks, as Acon plans to manufacture more than 100 million tests per month.

By F ebruary next year, the number is expected to increase to 200 million each month.

The F DA also noted that Acon’s F lowflex home test does not require serial testing depending on the data provided for asymptomatic individuals.

US F DA Center for Devices and Radiological Health director Jeffrey Shuren said: “We believe at-home diagnostic tests play a critical role in the fight against Covid-19.

“We will continue to offer support and expertise to help with the development of appropriately accurate and reliable tests, and to facilitate increased access to tests for all Americans.”

Outside the US, the Acon’s F lowflex tests are already available in several countries, including extensive distribution in the UK through the National Health Service (NHS).

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network